Mary M. Kavurma

3.3k total citations
60 papers, 2.4k citations indexed

About

Mary M. Kavurma is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Mary M. Kavurma has authored 60 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 24 papers in Immunology and 16 papers in Oncology. Recurrent topics in Mary M. Kavurma's work include Cell death mechanisms and regulation (16 papers), Atherosclerosis and Cardiovascular Diseases (11 papers) and Angiogenesis and VEGF in Cancer (8 papers). Mary M. Kavurma is often cited by papers focused on Cell death mechanisms and regulation (16 papers), Atherosclerosis and Cardiovascular Diseases (11 papers) and Angiogenesis and VEGF in Cancer (8 papers). Mary M. Kavurma collaborates with scholars based in Australia, United Kingdom and Malaysia. Mary M. Kavurma's co-authors include Levon M. Khachigian, Martin R. Bennett, Siân P. Cartland, Belinda A. Di Bartolo, Fernando S. Santiago, Harry C. Lowe, Stuart A. Scott, Andrew H. Baker, Colin N. Chesterman and Isabelle Gorenne and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Mary M. Kavurma

56 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary M. Kavurma Australia 30 1.5k 751 413 285 280 60 2.4k
Guangjin Zhou United States 22 1.5k 1.0× 579 0.8× 354 0.9× 257 0.9× 184 0.7× 69 2.5k
Xudong Liao United States 17 1.3k 0.9× 707 0.9× 322 0.8× 260 0.9× 154 0.6× 21 2.1k
Chenghui Yan China 27 1.2k 0.8× 360 0.5× 403 1.0× 335 1.2× 239 0.9× 166 2.3k
David R. Soto‐Pantoja United States 28 1.0k 0.7× 862 1.1× 289 0.7× 317 1.1× 494 1.8× 58 2.3k
Alessia Angelin United States 21 2.0k 1.3× 810 1.1× 507 1.2× 446 1.6× 366 1.3× 33 3.1k
G. Brandon Atkins United States 22 2.0k 1.4× 404 0.5× 470 1.1× 182 0.6× 173 0.6× 28 2.9k
Jesang Ko South Korea 28 1.1k 0.7× 491 0.7× 313 0.8× 189 0.7× 399 1.4× 72 2.0k
Clint L. Miller United States 24 1.3k 0.9× 660 0.9× 285 0.7× 173 0.6× 142 0.5× 62 2.1k
Eva Bengtsson Sweden 28 785 0.5× 1.0k 1.3× 364 0.9× 414 1.5× 194 0.7× 87 2.5k
Can Shi China 23 947 0.6× 690 0.9× 417 1.0× 169 0.6× 160 0.6× 43 2.0k

Countries citing papers authored by Mary M. Kavurma

Since Specialization
Citations

This map shows the geographic impact of Mary M. Kavurma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary M. Kavurma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary M. Kavurma more than expected).

Fields of papers citing papers by Mary M. Kavurma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary M. Kavurma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary M. Kavurma. The network helps show where Mary M. Kavurma may publish in the future.

Co-authorship network of co-authors of Mary M. Kavurma

This figure shows the co-authorship network connecting the top 25 collaborators of Mary M. Kavurma. A scholar is included among the top collaborators of Mary M. Kavurma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary M. Kavurma. Mary M. Kavurma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stanley, Christopher P., et al.. (2026). Endothelial mitochondrial dysfunction in hypertension, diabetes, and atherosclerosis. Cardiovascular Research. 122(1). 19–32.
2.
Lee, Bob S. L., Renhua Song, Natalia Pinello, et al.. (2025). METTL14 promotes intimal hyperplasia through m6A-mediated control of vascular smooth muscle dedifferentiation genes. JCI Insight. 10(10).
3.
Cartland, Siân P., Hao Chen, Rupert Ecker, et al.. (2025). The FKBPL-based therapeutic peptide, AD-01, protects the endothelium from hypoxia-induced damage by stabilising hypoxia inducible factor-α and inflammation. Journal of Translational Medicine. 23(1). 309–309.
4.
Parmenter, Belinda, Mary M. Kavurma, Toby Richards, et al.. (2025). Unmet Needs and Opportunities for Australian Innovation and Clinical Research to Improve Quality of Life and Outcomes in Patients With Peripheral Artery Disease. Heart Lung and Circulation. 34(3). 225–234.
5.
Gray, Michael P., David S. Celermajer, Helen M. McGuire, et al.. (2024). Vascular Cytokines and Atherosclerosis: Differential Serum Levels of TRAIL, IL-18, and OPG in Obstructive Coronary Artery Disease. Biomolecules. 14(9). 1119–1119. 2 indexed citations
6.
Kavurma, Mary M., Carina Cutmore, Freda Passam, et al.. (2023). A hidden problem: peripheral artery disease in women. European Heart Journal - Quality of Care and Clinical Outcomes. 9(4). 342–350. 22 indexed citations
7.
Bartolo, Belinda A. Di, et al.. (2021). HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis. Journal of Diabetes Research. 2021. 1–10. 31 indexed citations
8.
Vaidya, Kaivan, Bradley Tucker, R. Kurup, et al.. (2020). Colchicine Inhibits Neutrophil Extracellular Trap Formation in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention. Journal of the American Heart Association. 10(1). e018993–e018993. 96 indexed citations
9.
Kavurma, Mary M., et al.. (2019). Repetitive hypoglycemia reduces activation of glucose-responsive neurons in C1 and C3 medullary brain regions to subsequent hypoglycemia. American Journal of Physiology-Endocrinology and Metabolism. 317(2). E388–E398. 9 indexed citations
10.
Cartland, Siân P., Gonzalo J. Martínez, S. E. J. Robertson, et al.. (2019). TRAIL-Expressing Monocyte/Macrophages Are Critical for Reducing Inflammation and Atherosclerosis. iScience. 12. 41–52. 38 indexed citations
11.
Kavurma, Mary M., et al.. (2018). Microglia in the RVLM of SHR have reduced P2Y12R and CX3CR1 expression, shorter processes, and lower cell density. Autonomic Neuroscience. 216. 9–16. 15 indexed citations
12.
Cartland, Siân P., Hanis Hazeera Harith, Lei Dang, et al.. (2017). Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice. Scientific Reports. 7(1). 1898–1898. 38 indexed citations
13.
Cartland, Siân P., et al.. (2016). Comparative Evaluation of TRAIL, FGF-2 and VEGF-A-Induced Angiogenesis In Vitro and In Vivo. International Journal of Molecular Sciences. 17(12). 2025–2025. 43 indexed citations
14.
Bartolo, Belinda A. Di & Mary M. Kavurma. (2014). Regulation and Function of Rankl in Arterial Calcification. Current Pharmaceutical Design. 20(37). 5853–5861. 6 indexed citations
15.
Bartolo, Belinda A. Di, Siân P. Cartland, Hanis Hazeera Harith, et al.. (2013). TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL. PLoS ONE. 8(9). e74211–e74211. 51 indexed citations
16.
Bartolo, Belinda A. Di, et al.. (2013). Correction: TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL. PLoS ONE. 8(9). 23 indexed citations
17.
Bartolo, Belinda A. Di, et al.. (2011). Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcification. Cardiovascular Research. 91(3). 537–545. 43 indexed citations
18.
Kavurma, Mary M. & Martin R. Bennett. (2007). Expression, regulation and function of trail in atherosclerosis. Biochemical Pharmacology. 75(7). 1441–1450. 62 indexed citations
19.
20.
Kavurma, Mary M. & Levon M. Khachigian. (2003). Sp1 Inhibits Proliferation and Induces Apoptosis in Vascular Smooth Muscle Cells by Repressing p21WAF1/Cip1 Transcription and Cyclin D1-Cdk4-p21WAF1/Cip1 Complex Formation. Journal of Biological Chemistry. 278(35). 32537–32543. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guangjin Zhou Breakdown of academic impact, for papers by Xudong Liao Breakdown of academic impact, for papers by Chenghui Yan Breakdown of academic impact, for papers by David R. Soto‐Pantoja Breakdown of academic impact, for papers by Alessia Angelin Breakdown of academic impact, for papers by G. Brandon Atkins Breakdown of academic impact, for papers by Jesang Ko Breakdown of academic impact, for papers by Clint L. Miller Breakdown of academic impact, for papers by Eva Bengtsson Breakdown of academic impact, for papers by Can Shi
Rankless by CCL
2026